—
Enter label dose
Trial reference
From your label
Enter your label dose — the gauge updates instantly.
15 weight-loss trials. Small, statistically non-significant pooled effect; authors concluded not clinically important. Outside Japan MD −0.04 kg (95% CI −0.5 to 0.4).
Educational only — not medical advice. Disclaimer.
NIH DSLD market slice
Bulk CSV dump 16 January 2026 · label entries through 2025. Disclosed amounts only — proprietary blends without gram weights excluded.
Trial floors
Primary
Cochrane weight-loss review · 800 mg over 12-13 weeks · Primary endpoint missed — 15 weight-loss trials. Small, statistically non-significant pooled effect; authors concluded not clinically important. Outside Japan MD −0.04 kg (95% CI −0.5 to 0.4).
Secondary
Dose-response meta (Lin 2020) · 800 mg over 8-12 weeks · Secondary outcomes only — Pooled −1.78 kg (95% CI −2.80 to −0.75). Waist reduction greater at ≥800 mg/day green tea preparations and duration <12 weeks. Heterogeneous extract types; part of effect is caffeine.
Label reading notes
- Lin meta used green tea preparation mg/day; EGCG-specific labels may not match extract totals in trials.
- Cochrane verdict: not clinically important; shelf math is not a weight-loss promise.
- Decaffeinated extracts show weaker or absent effects; thermogenic products often add 300–600 mg caffeine.
- FDA warnings on green tea extract and idiosyncratic hepatotoxicity at high doses or with fasting.
